Can ashwagandha interact with thyroid medication?

Ashwagandha, usually labelled Withania somnifera, is now a common herbal supplement in Australia. People using thyroid treatment need to know that it may alter thyroid hormone levels rather than act as a harmless addition to their daily routine.

The evidence is limited but meaningful. Small studies and case reports suggest ashwagandha can lower TSH and raise circulating thyroid hormones. That matters especially for someone already taking levothyroxine, because the combined effect could push thyroid levels too high.

Medication and supplement interactions are individual, and the right response depends on thyroid test results, dose and health history. A doctor or pharmacist should assess the combination before it is started, and any thyroid medicine adjustment should be made only after clinical review.

Possible effects on thyroid function

Ashwagandha appears to influence the hypothalamic-pituitary-thyroid axis. In some research, it reduced TSH and increased T4 or T3, which are markers used to assess thyroid function. The proposed effect may be stronger in people with subclinical hypothyroidism.

Direct interaction studies are scarce. A published case report described two patients with subclinical hypothyroidism developing thyrotoxicosis after adding ashwagandha to levothyroxine. This does not prove the same will happen to everyone, but it supports treating the combination as a genuine interaction risk.

Why levothyroxine needs particular care

Levothyroxine is the main concern because it directly replaces thyroid hormone and is commonly prescribed in Australia through the Pharmaceutical Benefits Scheme. If ashwagandha also increases thyroid activity, the combined exposure may cause symptoms of thyrotoxicosis even without changing the levothyroxine tablet.

Watch for palpitations, tremor, heat intolerance, agitation, sweating, unexplained weight loss or persistent insomnia. Chest pain, severe weakness, confusion or a very fast heart rate needs urgent medical assessment. Older adults and people with heart disease may face greater risk from excess thyroid hormone.

When a dose review may be appropriate

Dosage adjustment may be appropriate, but it is not automatic. A clinician reviewing the combination would usually compare symptoms with TSH, free T4 and sometimes T3 results. Repeat testing is commonly arranged about six to eight weeks after a dose change because thyroid levels take time to stabilise.

A lower TSH could lead the prescriber to reduce levothyroxine, while stopping ashwagandha might mean the opposite adjustment is needed later. Decisions should be based on one change at a time and documented, rather than repeatedly altering the tablet dose in response to isolated symptoms.

A cautious approach to combining products

If the treating clinician approves ashwagandha, introduce only one new product at a time. Advice on introducing a new supplement can help with gastrointestinal upset, which may result from taking a larger amount than the body tolerates. Keep the thyroid tablet schedule unchanged unless instructed otherwise.

Levothyroxine is usually taken on an empty stomach 30 to 60 minutes before breakfast, with consistent timing helping absorption. Calcium, iron and some antacids can interfere and are generally kept at least four hours apart. Ask the pharmacist where to place ashwagandha in the routine rather than moving levothyroxine yourself.

The Australian supplement market and regulation

The Australian market offers ashwagandha as capsules, powders and tonics through health-food stores, supermarkets, chemists and online marketplaces, including in Melbourne and Sydney. Busy commuters may add a scoop to coffee or breakfast without checking whether another medicine is present. Product strength and ingredients can vary considerably.

The Therapeutic Goods Administration regulates the manufacture, labelling and advertising of complementary medicines in Australia. Listed products carry an AUST L number, but this indicates inclusion in the Australian Register of Therapeutic Goods, not guaranteed effectiveness for thyroid conditions. Registered products such as prescription medicines receive fuller pre-market assessment.

Checking for other medication interactions

Medication reviews should include vitamins, teas and other herbal products, not just tablets. For example, St John’s wort interactions can reduce the effectiveness of hormonal contraceptives, another issue relevant to people managing thyroid conditions. The mechanism differs from ashwagandha, but the precaution is the same.

Ask a pharmacist or an Australian doctor to check the complete supplement list, especially if taking carbimazole, methimazole, diabetes medicines, sedatives, anticoagulants or medicines for blood pressure. Antithyroid drugs have different risks from levothyroxine, and there is little direct research on combining them with ashwagandha.

Recognising warning signs

Seek prompt advice if thyroid symptoms change after starting or stopping ashwagandha, or if the medicine is being taken without medical supervision. A baseline thyroid test can be useful, followed by repeat blood tests as directed. Keep a dated list of doses and symptoms to discuss at the next appointment.

Pregnancy, breastfeeding and a history of thyroid disease warrant particular caution because safety data are limited. People with hyperthyroidism should generally avoid ashwagandha unless their specialist advises otherwise. Any suspected interaction is easier to manage when the prescriber has clear records and reliable thyroid test results.